Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

Launched by JONSSON COMPREHENSIVE CANCER CENTER · Oct 29, 2014

Keywords

ClinConnect Summary

This clinical trial is investigating how certain inherited genetic changes, known as germ-line mutations, might influence the development of cancer. Researchers will collect blood and saliva samples from patients who have been diagnosed with cancer. By studying these samples, the doctors hope to better understand how these genetic mutations could affect a person's risk of developing cancer, how they respond to treatment, and how they contribute to cancer growth.

To participate in this study, you need to have a confirmed diagnosis of cancer, either through a tissue sample or a clinical diagnosis, and you must be able to understand and sign a consent form. The trial is open to individuals aged 65 and older, regardless of gender. If you decide to join, you can expect to provide blood and saliva samples, which will help researchers gather valuable information about the genetic factors involved in cancer. It’s important to note that if your cancer diagnosis cannot be confirmed, you will not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pathologically or clinical confirmed tissue diagnosis of a cancer
• • Ability to understand and the willingness to sign a written informed consent
• Exclusion Criteria:
• • Patients will be excluded if their cancer cannot be confirmed
• • Refusal to sign the informed consent